In another study, chronic myeloid leukemia (CML) cell lines resistant to tyrosine kinase inhibitors (TKIs) were treated with modified human Gal-9 (hGal-9). Here, LGALS9 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.